Repaglinide Tablets

Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients with type 2 diabetes. Repaglinide tablets were listed in China in 2000, and it is a Class B drug in the National Medical Insurance List. Repaglinide tablets have been listed as a drug for diabetic patients with renal insufficiency by many guidelines at home and abroad.

Repaglinide tablets brand name: Repaglinide Tablets

Characteristic: White or off-white tablet

Specification: repaglinide 0.5mg×30 tablets, repaglinide 0.5mg×60 tablets.

Indications：

It is used for type 2 diabetes (non-insulin-dependent) patients whose hyperglycemia cannot be effectively controlled by diet control, weight loss and exercise. When metformin alone cannot effectively control hyperglycemia, repaglinide tab 0.5 mgcan be combined with metformin. Treatment should start from the adjuvant treatment of diet control and exercise to reduce blood sugar during meals.

Specifications of Repaglinide Tablets: repaglinide 0.5 mg oral tablet

Usage and Dosage, Adverse reactions, Contraindications, Precautions：

Please refer to the package insert.

Medicine Interactions:

Some drugs are known to affect glucose metabolism. Therefore, doctors should consider possible drug interactions.

In vitro studies have shown that the metabolism of Repaglinide is affected by CYP2C8 and CYP3A4. Repaglinide was found to be a substrate for active liver uptake (organic anion transporter OATP1B1).

Data from clinical studies carried out in healthy volunteers show that CYP2C8 is the main enzyme in the metabolism of Repaglinide, while CYP3A4 has limited effects. But if the effect of CYP2C8 is inhibited, the effect of CYP3A4 will be relatively enhanced. Therefore, the metabolism and clearance of Repaglinide may be changed due to the inhibition or induction of cytochrome P450. Therefore, extreme caution should be exercised when using CYP2C8 and CYP3A4 inhibitors simultaneously with Repaglinide. Drugs that inhibit OATP1B1 (such as cyclosporine) may increase the plasma concentration of Repaglinide. ( For more details, please refer to the package insert.)

Storage: Similar to the storage of glimepiride tablets, tab repaglinide should also be shaded, sealed, kept in a dry place.

Packaging:

Aluminum plastic packaging, 15 pills/plate , 2 plates/box; 15 pills/plate, 4 plates/box, 15 pills/plate, 6 plates/box

Shelf life: 24 months

Founded in 1992, Beiluis mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Beilu Pharma Contrast Media. Beilu provides complete Contrast Media products suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading contrast media manufacturerin the Contrast Media field in China.

Other supplier products

	Iodixanol Injection	IodixanolInjection is a Contrast Media that is isotonic with plasma. It has excellent cardiac safety and renal safety, which is most comfortable to...
	CT/X-Ray Contrast Media	The main component of CT/X-ray Contrast Media is iodine. The Iodinated Contrast Media is a colorless, transparent, slightly viscous liquid. At pres...
	Anti-Diabetic Drugs	The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of th...
	Iohexol Injection	Iohexol Injection is a non-ionic Contrast Media. Compared with a traditional ionic Contrast Media, Iohexol Injection has an excellent molecular str...
	Gadopentetate Dimeglumine Injection/API	Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic...

供应产品

Same products

	Calcobutrol	卖方: 北京北陆药业股份有限公司	Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Qual...
	Repaglinide Tablets	卖方: 北京北陆药业股份有限公司	Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients w...
	MRI Contrast Media	卖方: 北京北陆药业股份有限公司	agnetic resonance imaging Contrast Media (MRI Contrast Media), also called Magnetic resonance ima...
	Iopamidol Injection	卖方: 北京北陆药业股份有限公司	IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the gl...
	Iohexol Injection	卖方: 北京北陆药业股份有限公司	Iohexol Injection is a non-ionic Contrast Media. Compared with a traditional ionic Contrast Media...